With regard to the role of leptin in the crosstalk between obesity and breast cancer as aforementioned, our findings suggest that suppression of SREBP‐1‐dependent lipogenesis is a potential intervention for disrupting obesity‐cancer axis. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.